NCT03321968 Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults Status COMPLETED Phase PHASE3
NCT03312699 Effects of Aging on Primary and Secondary Vaccine Responses Status COMPLETED Phase PHASE1
NCT03308825 Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines Status COMPLETED Phase PHASE4
NCT03301051 Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults Status COMPLETED Phase PHASE3
NCT03300050 Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine Status COMPLETED Phase PHASE1
NCT03293498 Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu) Status COMPLETED Phase PHASE1/PHASE2
NCT03287830 Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine Status COMPLETED Phase NA
NCT03282240 Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US Status COMPLETED Phase PHASE3
NCT03266237 The Immune Response to Influenza Vaccinations in Elderly Individuals Status COMPLETED Phase PHASE4
NCT03248960 Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction. Status COMPLETED Phase NA
NCT03239665 Vaccination Education Through Pharmacists and Senior Centers (VEPSC) Status COMPLETED Phase NA
NCT03233217 Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years Status COMPLETED Phase PHASE1/PHASE2
NCT03232567 Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX Status COMPLETED Phase PHASE2
NCT03186781 Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults Status COMPLETED Phase PHASE1
NCT03180801 Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model Status COMPLETED Phase PHASE2